Developer docs
API playgroundTry for free, no card

Search company profiles

Celula

Full company profile

uuid00037ss

Namestring
Celula
Legal namestring
赛雷纳(中国)医疗科技有限公司
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Celula (赛雷纳(中国)医疗科技有限公司) is a Chengdu-headquartered, privately held in-vitro diagnostics (IVD) company founded in 2013 that develops and sells reproductive-health and clinical diagnostics products to hospitals, prenatal diagnosis centers, andrology departments, and immunology units across China. The portfolio is organized across three pillars: a genetic testing line under the AssuriT brand covering targeted NIPT (AssuriT-A/A+), single-gene NIPD (AssuriT-MD from 7 weeks gestation), three-in-one WES/CMA/CNV-seq molecular diagnostics (AssuriT-eWES-Dx), and expanded carrier screening (AssuriT-CS); a flow cytometry instrument line branded Sparrow, paired with Nest auto-sampling and Skyline/Skyline Pro automated sample processing modules, the CeK cytokine prep system, the CeM dilutor, and the CeQ high-throughput fluorescence quantifier; and a sperm function reagent series covering DNA fragmentation, acrosome reaction, mitochondrial membrane potential, nuclear DNA integrity, leukocytes, apoptosis, ROS, and plasma membrane integrity, alongside TBNK and 12-plex cytokine detection reagents. The proprietary technical foundation is a targeted amplicon sequencing NIPT architecture that lifts target chromosome sequence proportion by over 10x and achieves 500x coverage per SNP site at 3–5x lower sequencing cost than whole-genome approaches, complemented by an LD-PCR+NGS expanded carrier screening chemistry and a miniaturized NMPA Class II-registered flow cytometer offering up to seven laser/detector configurations.

Revenue is generated through one-time hardware sales of flow cytometers, automated sample processors, and supporting instruments, plus recurring consumable revenue from registered reagent kits, distributed through direct enterprise field sales teams in Chengdu and Shanghai targeting Chinese clinical institutions. The company supplements field sales with event-driven promotion via Chinese Medical Association andrology conferences, China Eugenics Association meetings, and content marketing on its own website, with a cooperation partnership with the First Affiliated Hospital of Naval Medical University for co-developed NIPD research. Operationally, the firm runs a roughly 100-person multidisciplinary technology and marketing team from a 5,000+ sqm Chengdu R&D, production, and service base, with wholly owned sales and regional offices in Shanghai, Zhuhai, and Beijing, and a US technology office in San Diego.

Short descriptiontext

Celula is a Chengdu-based Chinese IVD company founded in 2013 that designs, manufactures, and sells reproductive-health and clinical diagnostics products — including the Sparrow miniaturized flow cytometer, NIPT and carrier-screening kits under the AssuriT brand, and sperm-function reagent kits — to hospitals, prenatal diagnosis centers, and andrology departments across China.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersChengdu, China
HQ citystring
Chengdu
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
reproductive health diagnostics, flow cytometry instruments, prenatal genetic testing, clinical IVD reagents, non-invasive prenatal testing
Industry5 codes
PRIMARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Reproductive Health Diagnostics
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Flow Cytometry Instruments and Reagent Kits
TypeHardware Sales
Description

Sale of Sparrow series miniaturized flow cytometers and配套试剂盒 (supporting reagent kits) for reproductive health and immunology testing. Instruments sold with matching registered reagent products forming a closed-loop detection ecosystem.

celula-china.com
2Molecular Diagnostics Tests (NIPT, Carrier Screening, eWES)
TypeOne Time License
Description

Sale of genetic testing kits and reagents for prenatal screening, carrier screening, and molecular diagnostics including NIPT, NIPT-Plus, NIPT-eWES, AssuriT-eWES-Dx, and single-gene disease NIPD solutions.

celula-china.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1Sparrow Flow Cytometer (instrument) - no public pricing listed
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Listed as ¥0.00 on website; pricing likely quote-based through enterprise sales

celula-china.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1AssuriT
Description

品牌系列,包括AssuriT-A (NIPT)、AssuriT-A+ (NIPT Plus)、AssuriT-eWES、AssuriT-CS (携带者筛查)、AssuriT-MD (单基因病NIPD)等基因检测产品线。

celula-china.com
+4 more records
Core offering1 text field

Celula designs, manufactures, and sells reproductive health-focused in-vitro diagnostic (IVD) products, including its proprietary Sparrow miniaturized flow cytometry platform with supporting reagent kits, and the AssuriT series of molecular diagnostic kits covering non-invasive prenatal testing (NIPT), single-gene NIPD, expanded carrier screening, and three-in-one molecular diagnostics (WES/CMA/CNV-seq). The company's integrated instrument-plus-reagent solutions are sold to hospitals and clinical laboratories across China for prenatal screening, infertility diagnosis, and reproductive immunology testing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Targeted NIPT increases target chromosome sequence proportion by over 10x vs whole-genome sequencing
+4 more records
Product overview1 text field

Celula (赛雷纳(中国)医疗科技有限公司) is a reproductive health-focused IVD company offering a multi-product portfolio organized across three main categories: (1) Genetic Testing — including AssuriT-A/A+ NIPT, AssuriT-MD single-gene NIPD, AssuriT-eWES series (Dx three-in-one molecular diagnostics and NIPT-eWES), and AssuriT-CS carrier screening products; (2) Flow Cytometry Instruments and Reagents — including Sparrow flow cytometer (with Nest auto-loading module and Skyline/Skyline Pro automated sample processing systems, CeM dilutor), supported by TBNK and cytokine detection reagent kits; and (3) Sperm Function Detection — a full suite of flow cytometry-based sperm quality reagents covering DNA fragmentation, acrosome reaction, mitochondrial membrane potential, nuclear DNA integrity, leukocytes, apoptosis, ROS, and plasma membrane, plus combination reagent kits. The CeQ high-throughput fluorescence quantitative instrument rounds out the instrument portfolio. The company also offers the CeK automated cytokine sample preparation instrument for integration with Sparrow. All instruments and reagents are designed as an integrated ecosystem for reproductive health, prenatal screening, and clinical diagnosis across tiered medical institutions in China.

Product and service17 records
1Sparrow Flow Cytometer (Sparrow流式细胞仪)
CategoryFlow Cytometry Instruments
Description

A miniaturized benchtop flow cytometer for clinical diagnostics, featuring active light path adjustment technology, support for up to 7 laser/detector configurations, 30,000 particles/second detection speed, and NMPA Class II medical device registration. Designed for reproductive health and immunology applications across tiered medical institutions in China.

2Nest Automatic Loading Module (Nest自动上样模块)
CategoryFlow Cytometry Instruments
Description

An automatic sample loading module designed for the Sparrow series flow cytometer, enabling batch processing of up to 45 samples per run with intelligent mixing, emergency priority queuing, dynamic sample addition, and fault auto-alarm features.

3Skyline Automated Sample Processing System (Skyline全自动样本处理系统)
CategoryAutomated Sample Processing Instruments
Description

A fully automated sample processing platform that can serve as a companion to the Sparrow flow cytometer or operate independently. Performs sample dilution, antibody addition, mixing/incubation, and reagent addition workflows, handling up to 45 samples per run with full TBNK detection pre-processing.

4CeK Automated Cytokine Sample Preparation Instrument (CeK细胞因子全自动样本制备仪)
CategoryAutomated Sample Processing Instruments
Description

A fully automated sample preparation device customized for cytokine detection, completing standard curve dilution, reaction system configuration, incubation, and transfer to flow cytometer. Paired with Sparrow for fully automated cytokine detection. Features high-precision pipetting (CV ≤ 5%) and compact design under 60 cm width.

5Skyline Pro Automated Sample Processing Instrument (Skyline Pro全自动样本处理仪)
CategoryAutomated Sample Processing Instruments
Description

A modular multi-function automated sample processing platform integrating tri-axis motion control, sample mixing, temperature-controlled incubation, magnetic bead separation, thermal cycling (PCR), high-precision pipetting, and microplate transfer. Supports sample dilution, nucleic acid extraction, library construction, and DNA amplification workflows.

6CeM Dilutor (CeM稀释仪)
CategoryLaboratory Instruments
Description

A high-throughput dilutor compatible with 96-well and 48-well plates, offering multi-size diluent well positions. Uses high-precision syringe pump with dilution accuracy of ±0.5 μL, single dispensing volume > 100 μL, and compact design under 60 cm width. Used in DNA dilution and library dilution workflows.

7CeQ High-Throughput Fluorescence Quantitative Instrument (CeQ高通量荧光定量仪)
CategoryLaboratory Instruments
Description

A high-throughput fluorescence quantitative instrument for DNA sample quantification and qualitative analysis, with 96 independent detection channels, detection sensitivity of 0.05 ng/μL using PMT detector, and 96-sample detection in under 5 minutes. Used in environmental monitoring and genetic testing.

8AssuriT-A NIPT (AssuriT-A 无创DNA产前检测)
CategoryGenetic Testing Reagents
Description

Non-invasive prenatal DNA testing based on targeted amplicon sequencing technology. Requires only 10 mL of maternal peripheral blood to assess fetal risk for trisomy 21, 18, and 13 with 500x coverage depth at disease-related detection sites.

9AssuriT-A+ NIPT Plus (AssuriT-A+)
CategoryGenetic Testing Reagents
Description

Upgraded NIPT that detects trisomy 21, 18, and 13 along with other chromosomal numerical abnormalities and chromosomal microdeletions/microduplications through enhanced algorithms. Targets pathogenic CNVs (pCNVs) with detection rate of 1.6–1.7%.

10AssuriT-MD Single-Gene NIPD (AssuriT-MD 单基因病NIPD)
CategoryGenetic Testing Reagents
Description

A non-invasive prenatal diagnosis solution using high-throughput sequencing and cffDNA haplotyping analysis for accurate detection of single-gene hereditary diseases from 7 weeks gestation without invasive procedures. Covers thalassemia, Duchenne muscular dystrophy (DMD), and spinal muscular atrophy (SMA).

11AssuriT-CS Expanded Carrier Screening (AssuriT-CS 单基因病扩展性携带者筛查)
CategoryGenetic Testing Reagents
Description

Expanded carrier screening products including a 16-gene panel covering common autosomal recessive diseases such as thalassemia, hereditary deafness, phenylketonuria, and SMA, plus AssuriT-eWES-CS for comprehensive genomic risk assessment covering genetic carrier status, adult-onset diseases, dynamic repeat expansion diseases, mitochondrial diseases, infertility markers, and pharmacogenomic variants.

12AssuriT-eWES-Dx Three-in-One Molecular Diagnostic (AssuriT-eWES-Dx 三合一分子诊断)
CategoryGenetic Testing Reagents
Description

A molecular diagnostic solution integrating Whole Exome Sequencing (WES), Chromosomal Microarray Analysis (CMA), and Copy Number Variation Sequencing (CNV-seq) into a single test. Detects sequence variants (SNV/indels), structural variants (CNV), mitochondrial diseases, and uniparental disomy (UPD) for prenatal diagnosis, pediatrics, oncology, and reproductive medicine.

13AssuriT-eWES-N Comprehensive NIPT (AssuriT-eWES-N NIPT-eWES)
CategoryGenetic Testing Reagents
Description

A comprehensive NIPT solution leveraging cell-free fetal DNA for full fetal genome screening. Detects chromosomal aneuploidy, genome-wide CNVs, single-gene diseases (dominant/recessive), uniparental disomy, mitochondrial mutations, and zygosity determination.

14Sperm Function Detection Product Series (精子功能检测产品系列)
CategoryFlow Cytometry Reagents
Description

A complete flow cytometry-based sperm function detection solution covering sperm DNA fragmentation, acrosome reaction, mitochondrial membrane potential, nuclear DNA integrity, leukocyte detection, apoptosis, reactive oxygen species, and plasma membrane integrity. Includes combination reagent kits for sperm DNA fragmentation + mitochondrial membrane potential and DNA fragmentation + ROS detection.

15TBNK Detection Reagent (TBNK检测试剂)
CategoryFlow Cytometry Reagents
Description

A flow cytometry reagent kit for identifying percentages and absolute counts of mature lymphocyte subsets (T lymphocytes, B lymphocytes, NK cells) using fluorescently labeled antibodies targeting CD45, CD3, CD19, CD16, and CD56 surface antigens for immune status evaluation.

16Cytokine Detection Reagent (细胞因子检测试剂)
CategoryFlow Cytometry Reagents
Description

A flow cytometry-based immunofluorescence reagent kit using fluorescent microspheres to quantitatively detect 12 human cytokines (TNF-α, IL-6, IL-2, IFN-γ, IL-4, IL-10, IL-8, IL-5, IL-1β, IFN-α, IL-17A, IL-12P70) in serum, plasma, or cell culture supernatant. Used in infection, autoimmune diseases, pancreatitis, unexplained fever, and ICU patients.

17Carrier & Newborn Screening Combined (携带者筛查&新生儿筛查二合一)
CategoryGenetic Testing Reagents
Description

A combined expanded carrier screening and newborn screening solution to identify individuals carrying pathogenic variants for genetic diseases, enabling couples to assess risk of passing single-gene diseases to offspring. Covers autosomal recessive and X-linked recessive inheritance patterns.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1海军军医大学第一附属医院生殖医学中心 (Reproductive Medicine Center, First Affiliated Hospital of Naval Medical University)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-10-28
Description

Celula collaborated with the Reproductive Medicine Center of the First Affiliated Hospital of Naval Medical University to co-develop non-invasive prenatal diagnosis technology for fetal hereditary colorectal cancer. Research results were published in the international journal Prenatal Diagnosis, contributing to birth defect prevention in China's fertility protection and repair efforts.

celula-china.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

BGI is the dominant Chinese NIPT and genomics provider with broad reproductive health testing; highly comparable to Celula in prenatal screening and downstream IVD testing, but operates as a much larger public genomics platform with hospital labs and a wider portfolio.

TypeDirect peer
Description

Berry Genomics is one of the leading Chinese NIPT and prenatal diagnostics developers with established NIPT, NIPT Plus, and expanded carrier screening kits; directly competes head-to-head with Celula's AssuriT line in the same hospital channels.

3Annoroad Gene Technology
TypeDirect peer
Description

Annoroad offers sequencing-based NIPT, carrier screening, and reproductive health diagnostics with hospital-channel sales across China; directly comparable to Celula's molecular diagnostic portfolio targeting OB/GYN and prenatal centers.

TypeDirect peer
Description

DAAN Gene is a major Chinese molecular diagnostics manufacturer with NMPA-registered IVD kits across infectious disease, genetic, and prenatal testing; comparable in clinical IVD product breadth and hospital distribution model.

TypeBroad incumbent
Description

Amoy Diagnostics is a Chinese oncology and genetic diagnostics company with NMPA-registered companion diagnostic and prenatal IVD kits; comparable in molecular diagnostic product development and clinical channel sales.

TypeBroad incumbent
Description

KingMed is one of China's largest third-party medical laboratory networks offering a broad menu of genetic, prenatal, and reproductive diagnostics; comparable to Celula as a downstream channel for NIPT/carrier screening services.

TypeBroad incumbent
Description

Beckman Coulter is a global leader in clinical flow cytometry instruments and reagents; comparable to Celula's Sparrow cytometer and immune cytokine/TBNK reagent portfolio, though serving a much broader global installed base.

TypeBroad incumbent
Description

BD Biosciences is a global flow cytometry and clinical immunology reagent leader; directly comparable to Celula's flow cytometry instrument and reagent business, though operating globally with a much larger product portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Celula

Reproductive Health Diagnosticscelula-china.com

Celula is a Chengdu-based Chinese IVD company founded in 2013 that designs, manufactures, and sells reproductive-health and clinical diagnostics products — including the Sparrow miniaturized flow cytometer, NIPT and carrier-screening kits under the AssuriT brand, and sperm-function reagent kits — to hospitals, prenatal diagnosis centers, and andrology departments across China.

What Celula does

Celula (赛雷纳(中国)医疗科技有限公司) is a Chengdu-headquartered, privately held in-vitro diagnostics (IVD) company founded in 2013 that develops and sells reproductive-health and clinical diagnostics products to hospitals, prenatal diagnosis centers, andrology departments, and immunology units across China. The portfolio is organized across three pillars: a genetic testing line under the AssuriT brand covering targeted NIPT (AssuriT-A/A+), single-gene NIPD (AssuriT-MD from 7 weeks gestation), three-in-one WES/CMA/CNV-seq molecular diagnostics (AssuriT-eWES-Dx), and expanded carrier screening (AssuriT-CS); a flow cytometry instrument line branded Sparrow, paired with Nest auto-sampling and Skyline/Skyline Pro automated sample processing modules, the CeK cytokine prep system, the CeM dilutor, and the CeQ high-throughput fluorescence quantifier; and a sperm function reagent series covering DNA fragmentation, acrosome reaction, mitochondrial membrane potential, nuclear DNA integrity, leukocytes, apoptosis, ROS, and plasma membrane integrity, alongside TBNK and 12-plex cytokine detection reagents. The proprietary technical foundation is a targeted amplicon sequencing NIPT architecture that lifts target chromosome sequence proportion by over 10x and achieves 500x coverage per SNP site at 3–5x lower sequencing cost than whole-genome approaches, complemented by an LD-PCR+NGS expanded carrier screening chemistry and a miniaturized NMPA Class II-registered flow cytometer offering up to seven laser/detector configurations.

Revenue is generated through one-time hardware sales of flow cytometers, automated sample processors, and supporting instruments, plus recurring consumable revenue from registered reagent kits, distributed through direct enterprise field sales teams in Chengdu and Shanghai targeting Chinese clinical institutions. The company supplements field sales with event-driven promotion via Chinese Medical Association andrology conferences, China Eugenics Association meetings, and content marketing on its own website, with a cooperation partnership with the First Affiliated Hospital of Naval Medical University for co-developed NIPD research. Operationally, the firm runs a roughly 100-person multidisciplinary technology and marketing team from a 5,000+ sqm Chengdu R&D, production, and service base, with wholly owned sales and regional offices in Shanghai, Zhuhai, and Beijing, and a US technology office in San Diego.

Celula firmographics

Firmographics
Name
Celula
Legal name
赛雷纳(中国)医疗科技有限公司
Website
https://celula-china.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
101–250 employees
Short description
Celula is a Chengdu-based Chinese IVD company founded in 2013 that designs, manufactures, and sells reproductive-health and clinical diagnostics products — including the Sparrow miniaturized flow cytometer, NIPT and carrier-screening kits under the AssuriT brand, and sperm-function reagent kits — to hospitals, prenatal diagnosis centers, and andrology departments across China.
Ownership category
akta.pro rank

Celula industry classification

Industry
Product category
Reproductive Health Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Keywords

  • Reproductive health diagnostics
  • Flow cytometry instruments
  • Prenatal genetic testing
  • Clinical IVD reagents
  • Non-invasive prenatal testing

Where Celula is headquartered

Location

Headquarters

HQ city
Chengdu
HQ country
China
HQ region
Asia

Offices4 records

Markets served

Celula business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Flow Cytometry Instruments and Reagent Kits: Sale of Sparrow series miniaturized flow cytometers and配套试剂盒 (supporting reagent kits) for reproductive health and immunology testing. Instruments sold with matching registered reagent products forming a closed-loop detection ecosystem.
  2. Molecular Diagnostics Tests (NIPT, Carrier Screening, eWES): Sale of genetic testing kits and reagents for prenatal screening, carrier screening, and molecular diagnostics including NIPT, NIPT-Plus, NIPT-eWES, AssuriT-eWES-Dx, and single-gene disease NIPD solutions.

Pricing tiers

ModelBillingPrice
Unit PricingMulti-year contractSparrow Flow Cytometer (instrument) - no public pricing listed

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Celula product offering

Product offering

Core offering

Celula designs, manufactures, and sells reproductive health-focused in-vitro diagnostic (IVD) products, including its proprietary Sparrow miniaturized flow cytometry platform with supporting reagent kits, and the AssuriT series of molecular diagnostic kits covering non-invasive prenatal testing (NIPT), single-gene NIPD, expanded carrier screening, and three-in-one molecular diagnostics (WES/CMA/CNV-seq). The company's integrated instrument-plus-reagent solutions are sold to hospitals and clinical laboratories across China for prenatal screening, infertility diagnosis, and reproductive immunology testing.

Product overview

Celula (赛雷纳(中国)医疗科技有限公司) is a reproductive health-focused IVD company offering a multi-product portfolio organized across three main categories: (1) Genetic Testing — including AssuriT-A/A+ NIPT, AssuriT-MD single-gene NIPD, AssuriT-eWES series (Dx three-in-one molecular diagnostics and NIPT-eWES), and AssuriT-CS carrier screening products; (2) Flow Cytometry Instruments and Reagents — including Sparrow flow cytometer (with Nest auto-loading module and Skyline/Skyline Pro automated sample processing systems, CeM dilutor), supported by TBNK and cytokine detection reagent kits; and (3) Sperm Function Detection — a full suite of flow cytometry-based sperm quality reagents covering DNA fragmentation, acrosome reaction, mitochondrial membrane potential, nuclear DNA integrity, leukocytes, apoptosis, ROS, and plasma membrane, plus combination reagent kits. The CeQ high-throughput fluorescence quantitative instrument rounds out the instrument portfolio. The company also offers the CeK automated cytokine sample preparation instrument for integration with Sparrow. All instruments and reagents are designed as an integrated ecosystem for reproductive health, prenatal screening, and clinical diagnosis across tiered medical institutions in China.

Differentiator

Problem solved

Functional benefit

Brands

  • AssuriT: 品牌系列,包括AssuriT-A (NIPT)、AssuriT-A+ (NIPT Plus)、AssuriT-eWES、AssuriT-CS (携带者筛查)、AssuriT-MD (单基因病NIPD)等基因检测产品线。
  • Sparrow
  • CeQ
  • CeK
  • CeM

Products and services

  • Sparrow Flow Cytometer (Sparrow流式细胞仪) A miniaturized benchtop flow cytometer for clinical diagnostics, featuring active light path adjustment technology, support for up to 7 laser/detector configurations, 30,000 particles/second detection speed, and NMPA Class II medical device registration. Designed for reproductive health and immunology applications across tiered medical institutions in China.
  • Nest Automatic Loading Module (Nest自动上样模块) An automatic sample loading module designed for the Sparrow series flow cytometer, enabling batch processing of up to 45 samples per run with intelligent mixing, emergency priority queuing, dynamic sample addition, and fault auto-alarm features.
  • Skyline Automated Sample Processing System (Skyline全自动样本处理系统) A fully automated sample processing platform that can serve as a companion to the Sparrow flow cytometer or operate independently. Performs sample dilution, antibody addition, mixing/incubation, and reagent addition workflows, handling up to 45 samples per run with full TBNK detection pre-processing.
  • CeK Automated Cytokine Sample Preparation Instrument (CeK细胞因子全自动样本制备仪) A fully automated sample preparation device customized for cytokine detection, completing standard curve dilution, reaction system configuration, incubation, and transfer to flow cytometer. Paired with Sparrow for fully automated cytokine detection. Features high-precision pipetting (CV ≤ 5%) and compact design under 60 cm width.
  • Skyline Pro Automated Sample Processing Instrument (Skyline Pro全自动样本处理仪) A modular multi-function automated sample processing platform integrating tri-axis motion control, sample mixing, temperature-controlled incubation, magnetic bead separation, thermal cycling (PCR), high-precision pipetting, and microplate transfer. Supports sample dilution, nucleic acid extraction, library construction, and DNA amplification workflows.
  • CeM Dilutor (CeM稀释仪) A high-throughput dilutor compatible with 96-well and 48-well plates, offering multi-size diluent well positions. Uses high-precision syringe pump with dilution accuracy of ±0.5 μL, single dispensing volume > 100 μL, and compact design under 60 cm width. Used in DNA dilution and library dilution workflows.
  • CeQ High-Throughput Fluorescence Quantitative Instrument (CeQ高通量荧光定量仪) A high-throughput fluorescence quantitative instrument for DNA sample quantification and qualitative analysis, with 96 independent detection channels, detection sensitivity of 0.05 ng/μL using PMT detector, and 96-sample detection in under 5 minutes. Used in environmental monitoring and genetic testing.
  • AssuriT-A NIPT (AssuriT-A 无创DNA产前检测) Non-invasive prenatal DNA testing based on targeted amplicon sequencing technology. Requires only 10 mL of maternal peripheral blood to assess fetal risk for trisomy 21, 18, and 13 with 500x coverage depth at disease-related detection sites.
  • AssuriT-A+ NIPT Plus (AssuriT-A+) Upgraded NIPT that detects trisomy 21, 18, and 13 along with other chromosomal numerical abnormalities and chromosomal microdeletions/microduplications through enhanced algorithms. Targets pathogenic CNVs (pCNVs) with detection rate of 1.6–1.7%.
  • AssuriT-MD Single-Gene NIPD (AssuriT-MD 单基因病NIPD) A non-invasive prenatal diagnosis solution using high-throughput sequencing and cffDNA haplotyping analysis for accurate detection of single-gene hereditary diseases from 7 weeks gestation without invasive procedures. Covers thalassemia, Duchenne muscular dystrophy (DMD), and spinal muscular atrophy (SMA).
  • AssuriT-CS Expanded Carrier Screening (AssuriT-CS 单基因病扩展性携带者筛查) Expanded carrier screening products including a 16-gene panel covering common autosomal recessive diseases such as thalassemia, hereditary deafness, phenylketonuria, and SMA, plus AssuriT-eWES-CS for comprehensive genomic risk assessment covering genetic carrier status, adult-onset diseases, dynamic repeat expansion diseases, mitochondrial diseases, infertility markers, and pharmacogenomic variants.
  • AssuriT-eWES-Dx Three-in-One Molecular Diagnostic (AssuriT-eWES-Dx 三合一分子诊断) A molecular diagnostic solution integrating Whole Exome Sequencing (WES), Chromosomal Microarray Analysis (CMA), and Copy Number Variation Sequencing (CNV-seq) into a single test. Detects sequence variants (SNV/indels), structural variants (CNV), mitochondrial diseases, and uniparental disomy (UPD) for prenatal diagnosis, pediatrics, oncology, and reproductive medicine.
  • AssuriT-eWES-N Comprehensive NIPT (AssuriT-eWES-N NIPT-eWES) A comprehensive NIPT solution leveraging cell-free fetal DNA for full fetal genome screening. Detects chromosomal aneuploidy, genome-wide CNVs, single-gene diseases (dominant/recessive), uniparental disomy, mitochondrial mutations, and zygosity determination.
  • Sperm Function Detection Product Series (精子功能检测产品系列) A complete flow cytometry-based sperm function detection solution covering sperm DNA fragmentation, acrosome reaction, mitochondrial membrane potential, nuclear DNA integrity, leukocyte detection, apoptosis, reactive oxygen species, and plasma membrane integrity. Includes combination reagent kits for sperm DNA fragmentation + mitochondrial membrane potential and DNA fragmentation + ROS detection.
  • TBNK Detection Reagent (TBNK检测试剂) A flow cytometry reagent kit for identifying percentages and absolute counts of mature lymphocyte subsets (T lymphocytes, B lymphocytes, NK cells) using fluorescently labeled antibodies targeting CD45, CD3, CD19, CD16, and CD56 surface antigens for immune status evaluation.
  • Cytokine Detection Reagent (细胞因子检测试剂) A flow cytometry-based immunofluorescence reagent kit using fluorescent microspheres to quantitatively detect 12 human cytokines (TNF-α, IL-6, IL-2, IFN-γ, IL-4, IL-10, IL-8, IL-5, IL-1β, IFN-α, IL-17A, IL-12P70) in serum, plasma, or cell culture supernatant. Used in infection, autoimmune diseases, pancreatitis, unexplained fever, and ICU patients.
  • Carrier & Newborn Screening Combined (携带者筛查&新生儿筛查二合一) A combined expanded carrier screening and newborn screening solution to identify individuals carrying pathogenic variants for genetic diseases, enabling couples to assess risk of passing single-gene diseases to offspring. Covers autosomal recessive and X-linked recessive inheritance patterns.

Quantifiable outcome

  • Targeted NIPT increases target chromosome sequence proportion by over 10x vs whole-genome sequencing
  • +4 more outcomes

Companies that use Celula

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Celula technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Celula partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • 海军军医大学第一附属医院生殖医学中心 (Reproductive Medicine Center, First Affiliated Hospital of Naval Medical University)coreStrategic or Co-development Partner · 28 October 2022Celula collaborated with the Reproductive Medicine Center of the First Affiliated Hospital of Naval Medical University to co-develop non-invasive prenatal diagnosis technology for fetal hereditary colorectal cancer. Research results were published in the international journal Prenatal Diagnosis, contributing to birth defect prevention in China's fertility protection and repair efforts.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Celula competitors and assessment

Company assessment

Broad incumbents

  • BGI Genomics: BGI is the dominant Chinese NIPT and genomics provider with broad reproductive health testing; highly comparable to Celula in prenatal screening and downstream IVD testing, but operates as a much larger public genomics platform with hospital labs and a wider portfolio.
  • Amoy Diagnostics: Amoy Diagnostics is a Chinese oncology and genetic diagnostics company with NMPA-registered companion diagnostic and prenatal IVD kits; comparable in molecular diagnostic product development and clinical channel sales.
  • KingMed Diagnostics: KingMed is one of China's largest third-party medical laboratory networks offering a broad menu of genetic, prenatal, and reproductive diagnostics; comparable to Celula as a downstream channel for NIPT/carrier screening services.
  • Beckman Coulter Life Sciences: Beckman Coulter is a global leader in clinical flow cytometry instruments and reagents; comparable to Celula's Sparrow cytometer and immune cytokine/TBNK reagent portfolio, though serving a much broader global installed base.
  • BD Biosciences: BD Biosciences is a global flow cytometry and clinical immunology reagent leader; directly comparable to Celula's flow cytometry instrument and reagent business, though operating globally with a much larger product portfolio.

Direct peers

  • Berry Genomics: Berry Genomics is one of the leading Chinese NIPT and prenatal diagnostics developers with established NIPT, NIPT Plus, and expanded carrier screening kits; directly competes head-to-head with Celula's AssuriT line in the same hospital channels.
  • Annoroad Gene Technology: Annoroad offers sequencing-based NIPT, carrier screening, and reproductive health diagnostics with hospital-channel sales across China; directly comparable to Celula's molecular diagnostic portfolio targeting OB/GYN and prenatal centers.
  • DAAN Gene: DAAN Gene is a major Chinese molecular diagnostics manufacturer with NMPA-registered IVD kits across infectious disease, genetic, and prenatal testing; comparable in clinical IVD product breadth and hospital distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Celula financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Celula leadership team

Management profile

Number of profiles

Profiles2 records

Celula subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Celula funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Celula M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celula

What does Celula do?

Celula designs, manufactures, and sells reproductive health-focused in-vitro diagnostic (IVD) products, including its proprietary Sparrow miniaturized flow cytometry platform with supporting reagent kits, and the AssuriT series of molecular diagnostic kits covering non-invasive prenatal testing (NIPT), single-gene NIPD, expanded carrier screening, and three-in-one molecular diagnostics (WES/CMA/CNV-seq). The company's integrated instrument-plus-reagent solutions are sold to hospitals and clinical laboratories across China for prenatal screening, infertility diagnosis, and reproductive immunology testing.

Is Celula a public or private company?

Celula is a private company. It is classified as venture growth investor backed and is currently operating.

When was Celula founded?

Celula was founded in 2013. It employs 101 to 250 people.

Where is Celula based?

Celula is headquartered in Chengdu, China, in the Asia region.

How does Celula make money?

Two revenue lines are on record. Flow Cytometry Instruments and Reagent Kits are the primary driver. The others are molecular Diagnostics Tests (NIPT, Carrier Screening, eWES).

Who are Celula's main competitors?

Broad incumbents on record are BGI Genomics, Amoy Diagnostics, KingMed Diagnostics, Beckman Coulter Life Sciences and BD Biosciences. Direct peers are Berry Genomics, Annoroad Gene Technology and DAAN Gene.

Does Celula have an API?

No public API is recorded for Celula.

What industry is Celula in?

Celula's product category is Reproductive Health Diagnostics. Its primary akta.pro industry code is HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD, with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales